Jiangsu Hengrui Medicine Co., Ltd.
600276
Classement en actions
#543
Jiangsu Hengrui Medicine Co., Ltd. is a global biopharmaceutical firm engaged... Jiangsu Hengrui Medicine Co., Ltd. is a global biopharmaceutical firm engaged in the full spectrum of pharmaceutical operations, from the initial discovery and development of medications to their manufacturing and worldwide distribution. The company is actively advancing a substantial pipeline of drug candidates, which includes Apatinib, Pyrotinib, Mecapegfilgrastim, SHR3680, SHR3162, SHR9549, SHR2554, SHR1459, SHR-1309, SHR-A1201, Camrelizumab, Famitinib, SHR-1316, SHR-1501, SHR-1603, SHR-1701, SHR-1702, and SHR-A1403. These prospective treatments are aimed at a diverse range of medical conditions, primarily focusing on oncology, metabolic disorders, pain management, and autoimmune diseases, among others. The enterprise was founded in 1970 and maintains its corporate headquarters in Lianyungang, China.
Prix de l'action
$6.89
Capitalisation boursière
$43.94B
Changement (1 jour)
-2.91%
Changement (1 an)
-24.78%
Pays
CN
Échange Jiangsu Hengrui Medicine Co., Ltd. (600276)
Catégorie
Healthcare
Ratio P/S pour Jiangsu Hengrui Medicine Co., Ltd. (600276)
Ratio P/S au October 2026 TTM : 9.37
Selon les derniers rapports financiers et le cours de l'action de Jiangsu Hengrui Medicine Co., Ltd., le ratio cours/ventes actuel (TTM) est 9.37. À la fin de 2024, le ratio P/S était de 10.39.
Historique du ratio P/S pour Jiangsu Hengrui Medicine Co., Ltd. de 2001 à 2026
Ratio P/S à la fin de chaque année
| Année | Ratio P/S | Changez |
|---|---|---|
| 2026 (TTM) | 9.37 | -23.96% |
| 2025 | 12.32 | 18.54% |
| 2024 | 10.39 | -17.13% |
| 2023 | 12.54 | 8.76% |
| 2022 | 11.53 | -7.68% |
| 2021 | 12.49 | -41.32% |
| 2020 | 21.29 | 28.72% |
| 2019 | 16.54 | 47.69% |
| 2018 | 11.20 | -3.36% |
| 2017 | 11.59 | 44.55% |
| 2016 | 8.02 | -6.62% |
| 2015 | 8.58 | 63.97% |
| 2014 | 5.24 | -9.71% |
| 2013 | 5.80 | 21.57% |
| 2012 | 4.77 | -5.76% |
| 2011 | 5.06 | -38.70% |
| 2010 | 8.26 | 10.18% |
| 2009 | 7.49 | 29.72% |
| 2008 | 5.78 | -34.42% |
| 2007 | 8.81 | 78.87% |
| 2006 | 4.92 | 420.22% |
| 2005 | 0.95 | 14.31% |
| 2004 | 0.83 | -8.27% |
| 2003 | 0.90 | -28.02% |
| 2002 | 1.25 | -16.11% |
| 2001 | 1.50 | 0.00% |
Ratio P/S pour des entreprises similaires ou concurrentes
| Entreprise | Ratio P/S | Différence de Ratio P/S | Pays |
|---|---|---|---|
| - | - |
DE
|
|
| - | - |
DE
|
|
| 2.19 | -76.66% |
JP
|
|
| - | - |
CH
|
|
| 7.06 | -24.66% |
IN
|
